Price $2.05 |
Market Cap
29.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.19
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-15.1K
|
FCF
-1.2
|
|
Op. Margin
-0.60%
|
Net Margin
-2.60%
|
ROE
28.80%
|
ROI
-8.20%
|
|
ROA
-7.50%
|
EPS Growth
95.90%
|
Current Ratio
0.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Daxor Corporation (DXR) | $6.95 | - | 0.40% | 26.7M | Strong Buy |
| Nephros, Inc. (NEPH) | $0.27 | - | - | 16.2M | Strong Buy |
| Aoxing Pharmaceutical Company (AXN) | $0.36 | - | - | 29.3M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $6.70 | - | - | 76.3M | Strong Buy |
| Encision Inc (ECIA) | $0.40 | - | - | 3.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
